BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

154 hedge funds and large institutions have $427M invested in BioCryst Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 43 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
154
Holders Change
-11
Holders Change %
-6.67%
% of All Funds
3.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
25
Increased
62
Reduced
43
Closed
35
Calls
$4.4M
Puts
$4.64M
Net Calls
-$237K
Net Calls Change
-$8.12M

Top Buyers

1
SCM
1
Sarissa Capital Management
Connecticut
$16.7M
2
UBS Group
2
UBS Group
Switzerland
$4.94M
3
BlackRock
3
BlackRock
New York
$54.8M
4
Victory Capital Management
4
Victory Capital Management
Texas
$4.11M
5
State Street
5
State Street
Massachusetts
$55.6M

Top Sellers

1
EP
1
Eversept Partners
New York
$3.93M
2
ACP
2
Acuta Capital Partners
California
$2.27M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$4.8M
4
BBA
4
Baker Bros. Advisors
New York
$43.6M
5
Bank of America
5
Bank of America
North Carolina
$2.95M
Name Holding Trade Value Shares
Change 		Shares
Change %
EP
26
Eversept Partners
New York
$3.93M -$12.7M -3,704,581 -76%
Norges Bank
27
Norges Bank
Norway
$3.55M +$1.68M +488,600 +90%
WP
28
Woodline Partners
California
$2.98M -$2.48M -722,133 -45%
Bank of America
29
Bank of America
North Carolina
$2.95M -$3.2M -932,049 -52%
PHP
30
Parkman Healthcare Partners
Connecticut
$2.75M -$343K -99,868 -11%
SI
31
Sofinnova Investments
California
$2.73M -$1.94M -564,794 -42%
DCM
32
DAFNA Capital Management
California
$2.57M +$17.2K +5,000 +0.7%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.5M -$359K -104,484 -13%
PVI
34
Pura Vida Investments
New York
$2.48M +$980K +285,419 +65%
ACP
35
Acuta Capital Partners
California
$2.27M -$4.26M -1,240,000 -65%
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$2.17M -$876K -254,970 -29%
GGHC
37
Gilder Gagnon Howe & Co
New York
$2.03M +$2.03M +592,200 New
FAM
38
Formidable Asset Management
Ohio
$1.95M -$73.5K -21,800 -4%
Verition Fund Management
39
Verition Fund Management
Connecticut
$1.86M +$1.86M +541,839 New
Rafferty Asset Management
40
Rafferty Asset Management
New York
$1.81M +$1.04M +303,685 +136%
Wells Fargo
41
Wells Fargo
California
$1.61M -$39.3K -11,436 -2%
PIM
42
Platinum Investment Management
Australia
$1.59M – – –
TRCT
43
Tower Research Capital (TRC)
New York
$1.52M +$1.18M +343,144 +341%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.37M +$183K +53,342 +15%
DMK
45
David M. Knott
$1.37M – – –
Swiss National Bank
46
Swiss National Bank
Switzerland
$1.35M +$22.7K +6,600 +2%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.17M +$378K +110,100 +48%
Barclays
48
Barclays
United Kingdom
$987K -$295K -86,006 -23%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$918K +$114K +33,309 +14%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$912K -$36.9K -10,754 -4%
1
2
3 4 5